ViPOR's Venom - Rationally Targeting DLBCL with Precision

N Engl J Med. 2024 Jun 20;390(23):2209-2211. doi: 10.1056/NEJMe2405437.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Humans
  • Lenalidomide / administration & dosage
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Prednisone / administration & dosage

Substances

  • Antineoplastic Agents
  • venetoclax
  • ibrutinib
  • Prednisone
  • obinutuzumab
  • Lenalidomide